There’s a predator quietly spreading across North America that most people have never heard of. It looks a little like a coyote, behaves a little like a wolf, and has adapted to life in cities and suburbs better than almost any other wild carnivore on the continent.

It’s called the coywolf — and it’s one of the most fascinating examples of evolution happening in real time.

Whether you spotted one in your neighborhood or just came across the term for the first time, this article breaks down everything worth knowing: what a coywolf actually is, how it came to exist, what makes it physically and behaviorally unique, where it lives, and what science is still debating.

What Is a Coywolf?

A coywolf is a hybrid canid — a wild animal carrying the genetics of coyotes, wolves, and in most cases, domestic dogs. It is not a single clean cross between one coyote and one wolf. Instead, it represents several generations of interbreeding between western coyotes (Canis latrans), eastern wolves (Canis lupus lycaon), gray wolves (Canis lupus), and feral or domestic dogs (Canis lupus familiaris).

The result is an animal that blends traits from all three lineages. It’s larger than a typical coyote, smaller than a wolf, and far more comfortable around humans than either parent species.

Quick Answer

A coywolf is a hybrid canid found primarily in northeastern North America. It carries DNA from coyotes, eastern wolves, gray wolves, and domestic dogs — typically around 60–84% coyote, 8–25% wolf, and 8–11% dog. It is not an officially recognized species, but it is a genetically distinct and thriving population that has successfully adapted to forests, farmlands, and urban environments.

How Did the Coywolf Come to Exist?

The coywolf’s origin story is closely tied to human activity. Understanding it requires going back a few centuries.

Before European settlement, eastern wolves occupied most of northeastern North America. Western coyotes lived primarily in the plains and western regions. The two populations rarely, if ever, met.

Then things changed dramatically.

As settlers moved east, they cleared forests, hunted wolves aggressively, and fundamentally reshaped the landscape. Wolf populations collapsed. Entire regional populations were wiped out. Meanwhile, coyotes — far more adaptable and less targeted by hunters — began spreading eastward, filling the ecological space wolves had left behind.

As coyotes moved through the Great Lakes region in the early 20th century, they encountered remnant wolf populations. Because wolves and coyotes are closely related members of the Canis family, interbreeding was biologically possible. And with fewer wolves to mate with each other, the “prison effect” kicked in — animals with limited mate options will sometimes breed with the closest available relative. Some of that interbreeding also included feral and domestic dogs.

The result was a hybrid population carrying genetic contributions from all three. When these animals moved further east into New England and Atlantic Canada, they brought their mixed genetics with them. Every generation since has carried that blended DNA.

Coyote/wolf hybrids were first identified in the early 20th century, and the population has been reproducing successfully across generations ever since.

Is the Coywolf a Real Species?

This is where scientists have a genuine debate — and it’s worth understanding the distinction.

Technically, the coywolf is not a recognized species. In classical biology, a species is defined as a population that breeds among itself and produces fertile offspring. Coywolves do reproduce successfully. However, they continue to interbreed freely with both coyotes and wolves, which means the genetic boundaries are blurry rather than fixed.

Many researchers prefer the term eastern coyote when referring to these animals, arguing that “coywolf” overemphasizes the wolf contribution and implies a cleaner 50/50 split that doesn’t reflect genetic reality.

Others argue the coywolf represents something genuinely novel — a stable, expanding hybrid population with its own distinct ecological niche. That’s a rare thing in the animal kingdom, and some biologists think it deserves recognition.

For now, the scientific community hasn’t reached consensus. But there’s no question the animal exists, thrives, and is ecologically meaningful.

What Does a Coywolf Look Like?

Coywolves are noticeably larger than the western coyotes most people picture. Adults typically weigh between 35 and 55 pounds, compared to a western coyote’s 20–35 pounds. Some individuals push even larger, depending on how much wolf genetics they carry.

Several physical traits reflect the hybrid heritage:

• Head and muzzle: Broader and more prominent than a coyote’s, with a rounded jaw structure inherited from wolves. The skull is notably larger.
• Ears: Less pointed than a coyote’s, sitting wider on the head — a wolf-like trait.
• Legs and paws: Larger and more powerful than a coyote’s, suited for covering long distances.
• Tail: Bushier than a typical coyote’s, though shorter than a wolf’s.
• Coat color: Highly variable. Coywolves can range from tawny brown to reddish, dark gray, or almost black — reflecting the coat diversity of wolves and dogs in their ancestry.

The overall impression is of a coyote that’s been scaled up slightly, with a broader face and more substantial build. Side by side with a western coyote, the size difference is obvious.

Coywolf Genetics: The Numbers

Genetic testing has confirmed what early observations suggested. The exact breakdown varies by region and individual, but general averages from northeastern North America look like this:

• 60–84% coyote
• 8–25% wolf (a mix of eastern and gray wolf genetics)
• 8–11% domestic dog

Urban environments tend to favor higher coyote gene expression, while animals in deeper rural and forested areas typically carry more wolf content. This regional variation reflects both the different ancestral populations these animals descended from and the ongoing influence of their environment on which traits are advantageous.

The domestic dog contribution is small but meaningful. Dog genetics may have contributed to the coywolf’s reduced wariness of humans and its comfort in urban settings — traits that have helped it thrive in places most wild predators avoid.

How Does the Coywolf Behave?

Behavior is where the coywolf’s hybrid nature becomes most visible. It genuinely blends strategies from both parent species.

Hunting and Diet

Western coyotes mostly hunt alone, targeting small animals like rabbits, rodents, and birds. Wolves hunt in coordinated packs and can take down large prey like elk and moose.

Coywolves do both.

They form small social groups — typically three to five animals — that allow them to pursue white-tailed deer, which a lone coyote couldn’t reliably handle. At the same time, they forage opportunistically as individuals, eating everything from mice and rabbits to berries, insects, carrion, and garbage in urban environments.

This dietary flexibility is a significant evolutionary advantage. It means coywolves aren’t dependent on any single prey type, which makes them resilient across a wide range of environments.

Social Structure

Coywolf social groups are looser than wolf packs and less solitary than typical coyotes. A mated pair often stays together long-term, and offspring from previous seasons sometimes remain with the family group into the next year. That cooperative structure helps with raising pups and defending territory.

Vocalizations

Coywolves vocalize in a distinctive way that reflects their dual heritage. Their calls often begin with the low, sustained howl of a wolf, then break into the higher-pitched yipping sequences associated with coyotes. People living near coywolf populations often describe the sound as unlike anything they’ve heard from either species alone.

Urban Adaptation

One of the coywolf’s most remarkable traits is its comfort in cities and suburbs. GPS tracking studies have found coywolves using railroad corridors, highway medians, and urban green spaces to navigate through cities. They’re documented in New York City, Boston, Toronto, and across suburban neighborhoods throughout the northeast.

They tend to be most active at night in urban environments, limiting direct contact with people. Their diet in cities shifts toward rats, squirrels, rabbits, and Canada geese — animals that are often overabundant in urban settings.

Where Do Coywolves Live?

Coywolves are concentrated in northeastern North America, with the highest populations in Ontario, Quebec, and the Maritime provinces of Canada. In the United States, they’re well established across New England, New York, New Jersey, and increasingly further south along the Atlantic coast.

Population estimates are difficult to pin down precisely, but figures from around 2020 suggested somewhere between 100,000 and 500,000 in eastern Canada alone, with total North American numbers exceeding one million.

Their range continues to expand southward and westward, and sightings have been confirmed as far south as Virginia. As their range expands, so does public interest — and occasionally, public concern.

Are Coywolves Dangerous to Humans?

Coywolves are wild animals, and like all wild predators, they deserve respect and appropriate distance. That said, they are generally wary of humans and avoid confrontation.

Media coverage has sometimes exaggerated the risk. Coywolves living near human populations are not systematically attacking people or pets. They primarily pursue wild prey, and most encounters with humans result in the animal retreating.

That said, coywolves that have been fed by people — intentionally or accidentally — can lose their natural wariness. A coywolf comfortable enough to approach people is a coywolf that has been habituated, usually through human feeding. That’s the actual risk: not the animal itself, but the behavior changes that come from removing its natural caution.

If you encounter a coywolf:

• Do not approach, feed, or photograph it at close range
• Back away slowly without turning your back to run
• Make yourself look larger and make noise if it doesn’t retreat
• Keep pets on leashes in areas where coywolves are active
• Never leave pet food outside overnight

Attacks on humans are rare and almost always linked to prior habituation from people feeding wildlife.

Common Misconceptions About the Coywolf

“A coywolf is half coyote and half wolf.” Not quite. The genetics are much more complex. Most coywolves are 60–84% coyote, with wolf genetics comprising a smaller portion — plus a contribution from domestic dogs.

“Coywolves are a new, formal species.” Scientists are still debating this. They’re a genetically distinct hybrid population, but most researchers don’t classify them as a separate species yet because they continue to interbreed with both parent species.

“Coywolves are dangerous urban predators.” They’re wild animals that deserve respect, but the danger is frequently overstated. They primarily eat rodents, rabbits, and deer — not pets or people. Problems arise mainly from habituation caused by humans feeding wildlife.

“Pure coyotes and pure wolves still exist everywhere.” In much of eastern North America, truly “pure” coyotes are now quite rare. Because interbreeding has been widespread for generations, most eastern coyotes carry wolf and dog genetics to some degree.

“Coywolves only live in the wilderness.” They’re remarkably comfortable in cities. GPS tracking confirms their presence in some of North America’s largest urban centers, where they live mostly undetected.

Why the Coywolf Matters to Science

Beyond being an interesting animal, the coywolf tells scientists something important about evolution, hybridization, and adaptation.

Hybridization was long considered a biological dead end — the assumption being that hybrid animals were sterile or poorly adapted. The coywolf challenges that assumption directly. It’s fertile, thriving, and expanding its range. Its hybrid genetics haven’t made it weaker. In many ways, they’ve made it stronger.

Researchers studying the coywolf have found parallels with human evolutionary history. Humans, too, are genetic hybrids — our ancestors interbred with Neanderthals and Denisovans, and traces of that interbreeding remain in modern human DNA. The coywolf offers a living model for studying how hybridization shapes a population over relatively short timescales.

There’s also an ecological dimension. In regions where wolves were hunted to extinction, the coywolf has partially filled the role of apex predator — controlling deer populations, culling weak and sick animals, and influencing how prey species behave and where they graze. That role is imperfect and incomplete compared to a full wolf population, but it’s better than nothing.

Key Facts About the Coywolf

• Coywolves are a hybrid of coyotes, eastern wolves, gray wolves, and domestic dogs
• Typical genetic breakdown: 60–84% coyote, 8–25% wolf, 8–11% dog
• Coyote/wolf hybridization began in earnest in the early 20th century as wolf populations collapsed and coyotes expanded eastward
• They weigh roughly 35–55 pounds — larger than coyotes, smaller than wolves
• They form small social groups of 3–5 animals, larger than a lone coyote but smaller than a wolf pack
• Their howl blends the low sustained tone of a wolf with the high yipping of a coyote
• Estimated population exceeds one million in North America
• They’re well established in major cities including New York, Boston, and Toronto
• Urban environments tend to favor higher coyote gene expression; deep rural areas show higher wolf content
• They are not classified as an endangered or threatened species

Frequently Asked Questions

Q1: What exactly is a coywolf?

Ans: A coywolf is a wild canid hybrid found primarily in northeastern North America. It carries DNA from coyotes, eastern wolves, gray wolves, and domestic dogs — and is larger, more social, and more adaptable than a typical western coyote.

Q2: Is a coywolf a real animal or just a theory?

Ans: It’s real. Genetic testing has confirmed the hybrid ancestry of eastern coyotes across northeastern North America. Whether they constitute a distinct species is still debated, but the animals themselves are well-documented.

Q3: Can a coywolf interbreed with domestic dogs or wolves?

Ans: Yes. Coywolves remain reproductively compatible with coyotes, wolves, and dogs. This genetic openness is part of why classifying them as a separate species is complicated.

Q4: Are coywolves the same as eastern coyotes?

Ans: Largely yes. Many scientists prefer “eastern coyote” as the more accurate term, since “coywolf” implies a 50/50 hybrid split that doesn’t reflect the actual genetics. The two terms typically refer to the same population.

Q5: How did coywolves end up in cities?

Ans: Their partial domestic dog ancestry likely reduced their natural fear of humans and human environments. They’re intelligent, opportunistic, and use man-made corridors like railroad lines and highway medians to navigate urban landscapes. Cities offer abundant food — rodents, garbage, Canada geese — and relatively few natural predators.

Q6: Do coywolves pose a danger to pets?

Ans: Small pets left unsupervised outside are at some risk, particularly at night. Coywolves do occasionally take cats or small dogs. Keeping pets leashed, supervised, and indoors at night significantly reduces that risk.

Q7: Are coywolves protected by law?

Ans: Regulations vary by jurisdiction. In much of eastern North America, they can be legally hunted or trapped. In areas where they may carry wolf genetics, there have been legal debates about whether hunting regulations designed for coyotes appropriately apply. The eastern wolf — one of their parent species — is listed as a species of special concern in Canada.

Q8: Will the coywolf eventually replace the coyote?

Ans: Unlikely. Because coywolves continue to interbreed freely with pure coyotes (and wolves), the genetic boundaries remain fluid. What’s more likely is that eastern coyote populations will continue to carry varying degrees of wolf and dog genetics depending on their local environment and available mates.

Key Takeaways

• The coywolf is a genetically complex hybrid of coyotes, wolves, and domestic dogs — not a simple 50/50 cross
• It emerged in the early 20th century as wolf populations collapsed and coyotes expanded eastward, filling vacant ecological niches
• It’s larger and more social than a western coyote, with wolf-like skull features, a bushier tail, and stronger legs
• It hunts both small prey alone and large prey like deer in small groups — a behavioral flexibility neither parent species fully shares
• Millions now live across northeastern North America, including in major urban centers, where they fill the role of a mid-level predator
• It is not a recognized species, but it is a thriving, reproducing, and ecologically significant population
• Its existence challenges old assumptions about hybridization and offers a real-world model for understanding rapid adaptation

The coywolf didn’t emerge because scientists designed it. It appeared because humans reshaped the landscape, eliminated wolves, and created the conditions for something new to fill the gap. What filled it was an animal with just enough wolf to take down a deer, just enough coyote to survive almost anywhere, and just enough dog to feel comfortable walking through a city without looking back.

Latest non domiciled CDL news: FMCSA’s 2026 Final Rule restricts eligibility to H-2A, H-2B, and E-2 visa holders. Learn who qualifies, who doesn’t, and what changes mean for you.

Few regulatory changes in recent memory have shaken the commercial trucking industry as quickly as the federal government’s overhaul of non-domiciled CDL rules. Since September 2025, thousands of commercial drivers have faced uncertainty about their licenses, some states have paused issuing these credentials altogether, and a string of federal court challenges has kept the situation fluid. If you hold a non-domiciled CDL — or employ drivers who do — this is what you need to know.

What Is a Non Domiciled CDL News?

A non-domiciled Commercial Driver’s License (CDL) is a commercial driving credential issued by a U.S. state to someone who does not live in that state or is domiciled in a foreign country. The term “non-domiciled” must be prominently displayed on the license itself.

There are two main scenarios where this license applies:

• A person living outside the United States who needs to operate commercial motor vehicles (CMVs) within the country
• A person who lives in a state that cannot issue CDLs and obtains one from another eligible state instead

For most of the past decade, states issued these licenses with relatively few restrictions. Foreign nationals presenting a valid Employment Authorization Document (EAD) could generally qualify, which allowed DACA recipients, refugees, asylum seekers, and Temporary Protected Status (TPS) holders to enter commercial trucking. That framework has now been significantly tightened.

The 2025–2026 Rule Changes: A Timeline

September 29, 2025 — The Interim Final Rule

On September 26, 2025, U.S. Transportation Secretary Sean Duffy announced an emergency Interim Final Rule (IFR), which took effect three days later on September 29. The rule was titled Restoring Integrity to the Issuance of Non-Domiciled Commercial Driver’s Licenses and immediately restricted which immigration categories could qualify for a non-domiciled CDL or Commercial Learner’s Permit (CLP).

The FMCSA cited two primary reasons for acting on an emergency basis rather than through the normal notice-and-comment rulemaking process. First, it pointed to a series of fatal crashes involving non-domiciled CDL holders — specifically citing 17 fatal crashes in 2025 resulting in 30 deaths. Second, it identified a structural safety gap: domestic CDL applicants face background checks through federal databases like CDLIS (Commercial Driver License Information System) and PDPS (Problem Driver Pointer System), while non-domiciled applicants had no equivalent verification of their foreign driving histories.

The agency also highlighted that some states had been issuing these licenses to individuals presenting expired passports — a practice that created what it described as a “loophole” for drivers with dangerous records overseas.

Several states, including Texas, complied immediately. Others, including California, Washington, Colorado, and Pennsylvania, paused non-domiciled CDL processing while reviewing their compliance with federal requirements.

November 2025 — Federal Court Issues a Stay

The IFR faced immediate legal pushback. Petitioners in a case called Rivera Lujan v. FMCSA — led by DACA recipient and owner-operator Jorge Rivera Lujan and represented by Public Citizen Litigation Group — argued the rule was issued without required public notice, violated administrative procedure requirements, and threatened the livelihoods of nearly 200,000 people who had already been granted work authorization.

In November 2025, the U.S. Court of Appeals for the D.C. Circuit issued an administrative stay, temporarily pausing enforcement of the IFR while the court reviewed the challenge. This stay created several months of regulatory uncertainty for both drivers and employers.

February 13, 2026 — The Final Rule

On February 13, 2026, FMCSA published a Final Rule that replaced the IFR. It adopted the core restrictions of the interim rule with minor adjustments and took effect on March 16, 2026. Because the Final Rule was a new rulemaking, it rendered the IFR moot for legal purposes — and effectively restarted the legal challenge clock.

As of mid-2026, litigation continues in the D.C. Circuit, with petitioners seeking to block enforcement of the Final Rule as well.

Who Can Still Get a Non-Domiciled CDL?

Under the Final Rule effective March 16, 2026, eligibility for a non-domiciled CDL or CLP is limited to individuals holding one of three specific employment-based nonimmigrant visa categories:

• H-2A — Temporary agricultural workers
• H-2B — Temporary non-agricultural workers
• E-2 — Treaty investors

These categories were selected because FMCSA considers the vetting processes for these visas comparable in rigor to the domestic CDL background check system.

To obtain, renew, transfer, or upgrade a non-domiciled credential, eligible drivers must now provide both an unexpired passport and a Form I-94 or I-94A showing their approved employment-based visa status. Employment Authorization Cards (EAC/EAD) alone are no longer accepted.

The validity period of a non-domiciled CDL is now tied to the driver’s immigration documents, with a maximum of one year per issuance. Renewals require updated proof of status.

Who Is No Longer Eligible?

The following immigration categories are no longer eligible for new non-domiciled CDL issuance, renewal, upgrade, or transfer under the current rule:

• DACA recipients (Deferred Action for Childhood Arrivals)
• Asylum seekers and asylees
• Refugees
• Temporary Protected Status (TPS) holders
• Humanitarian parolees
• People with pending adjustment of status
• General EAD holders not associated with an H-2A, H-2B, or E-2 visa

Drivers who currently hold a valid non-domiciled CDL under a now-excluded category can generally continue operating until their license expires. However, they will not be able to renew it under the current rule unless their immigration status changes to a qualifying category.

It’s worth noting that Canadian and Mexican commercial drivers are not affected by this rule. They operate under separate licensing reciprocity agreements and hold their home country’s commercial credentials.

How Many Drivers Are Affected?

FMCSA estimates that approximately 194,000 non-domiciled CDL holders could eventually be affected by the revised eligibility standards. Some industry analyses place the potential total workforce impact — accounting for those who cannot renew as licenses expire over the next two to five years — as high as 214,000 to 437,000 drivers.

Because most properly issued non-domiciled CDLs have validity periods of up to five years, the impact on the active driver pool will be gradual rather than immediate. The disruption accelerates as licenses reach their expiration dates and renewal under the new rules becomes required.

Industries that rely heavily on foreign-born workers — including agriculture, waste management, construction, and long-haul trucking — are watching this closely.

What Is Happening in California?

California became one of the most high-profile states affected by this rule change, largely because of the scale of its non-domiciled CDL population.

In November and December 2025, the California DMV sent cancellation notices to approximately 20,000 non-domiciled CDL holders, citing issues with expiration dates on their commercial licenses and work authorization documents. In December 2025, Asian Law Caucus, the Sikh Coalition, and law firm Weil, Gotshal & Manges filed a class-action lawsuit to prevent those cancellations from taking effect.

However, the court did not block the underlying license cancellations. As of mid-2026, the California DMV is accepting applications but has not yet resumed issuing non-domiciled CDLs.

What This Means for Motor Carriers

Motor carriers employing non-domiciled CDL holders face real practical burdens under the new rule.

For drivers affected by the rule, any licensing transaction — including an address change — now triggers verification requirements. Carriers should proactively audit their driver files to identify who holds a non-domiciled CDL and what their current immigration status is.

For companies like Waste Pro, the impact has been immediate. The waste management company reported that some of its drivers lost their credentials with little or no advance notice despite holding active Employment Authorization Documents, causing service delays and forcing it to reassign employees to non-CDL roles.

Key steps for motor carriers right now include reviewing all driver qualification files, establishing protocols for handling potential CDL expirations or cancellations, budgeting additional time for compliance-related administrative tasks, and monitoring ongoing court rulings — particularly from the D.C. Circuit.

The Safety Argument vs. the Workforce Argument

This rule has created a genuine tension between two legitimate concerns.

On the safety side, FMCSA’s argument is that the previous system allowed individuals to obtain commercial driving credentials without any verification of their overseas driving records. A domestic applicant with a history of dangerous driving would be flagged through federal databases. A non-domiciled applicant with the same history could, in theory, present a work authorization document and pass the licensing process cleanly. The agency cited specific fatal crashes as evidence that this gap was not hypothetical.

On the workforce side, critics — including trucking associations, immigrant advocacy groups, and some state governments — argue that the rule is too blunt. It removes workers who are lawfully authorized to work in the United States, have clean U.S. driving records, and have caused no safety concerns. Industry groups have warned of significant driver shortages in sectors already struggling to fill commercial driving positions, potentially leading to supply chain disruptions.

Both arguments reflect real data. The debate is ultimately about how to weigh road safety against workforce policy — and that question is now partly in the hands of the federal courts.

Key Facts

• The FMCSA Final Rule titled Restoring Integrity to the Issuance of Non-Domiciled CDLs took effect March 16, 2026
• Only H-2A, H-2B, and E-2 visa holders are eligible for new non-domiciled CDL issuance under the current rule
• Employment Authorization Documents (EADs) alone are no longer accepted as proof of eligibility
• FMCSA estimates approximately 194,000 current CDL holders could be affected
• Drivers with valid licenses can continue operating until expiration, but cannot renew if they don’t meet the new criteria
• The rule is being challenged in the U.S. Court of Appeals for the D.C. Circuit
• California, Washington, Colorado, and Pennsylvania paused non-domiciled CDL processing following the September 2025 IFR
• The rule does not affect Canadian or Mexican commercial drivers operating under reciprocity agreements

Common Misconceptions

Non-domiciled CDL holders are all undocumented immigrants

Not true. The vast majority of non-domiciled CDL holders had lawful work authorization when they obtained their licenses. The rule change affects people with legal immigration status — DACA recipients, refugees, asylum seekers — not people in the country without authorization.

The rule immediately cancels all existing non-domiciled CDLs

It does not. Existing licenses generally remain valid until they expire. The restriction applies to new issuances, renewals, transfers, and upgrades going forward.

Only truckers are affected

The rule covers anyone who holds a non-domiciled CDL to operate any commercial motor vehicle — including bus drivers, waste haulers, agricultural equipment operators, and construction vehicle operators.

Canadian and Mexican drivers will lose their licenses

This rule does not apply to drivers licensed in Canada or Mexico. Existing reciprocity agreements for those countries remain in effect.

If the court blocks the rule, everything goes back to normal

A court stay would pause enforcement, but it wouldn’t automatically restore canceled licenses or resolve the underlying administrative procedures. State agencies would still need to reopen their processes, which takes time.

Frequently Asked Questions

Q1: What is a non-domiciled CDL?

ANS: A non-domiciled CDL is a Commercial Driver’s License issued by a U.S. state to a person who does not live in that state or is domiciled in a foreign country. The license must display the words “non-domiciled” prominently.

Q2: Who qualifies for a non-domiciled CDL under the 2026 rule?

ANS: Under the Final Rule effective March 16, 2026, only individuals holding H-2A (temporary agricultural), H-2B (temporary non-agricultural), or E-2 (treaty investor) nonimmigrant visas are eligible. All other categories, including DACA, TPS, refugees, and general EAD holders, are excluded from new issuances.

Q3: Can I still drive with a non-domiciled CDL?

ANS: Yes, generally. If your license was validly issued before the rule change, you can continue operating until it expires. However, you cannot renew it unless your immigration status meets the current eligibility criteria.

Q4: Why did FMCSA change the non-domiciled CDL rules?

ANS: FMCSA cited a safety gap — non-domiciled applicants had no equivalent to the federal database checks used for domestic CDL applicants, making it possible for drivers with dangerous foreign driving records to obtain a U.S. CDL. The agency also cited specific fatal crashes in 2025 involving non-domiciled CDL holders.

Q5: Is the new rule being challenged in court?

ANS: Yes. As of mid-2026, active litigation continues in the U.S. Court of Appeals for the D.C. Circuit, with petitioners arguing the rule was issued improperly and causes irreparable harm to lawfully authorized workers. Carriers and drivers should monitor developments closely.

Q6: What does this mean for trucking companies?

ANS: Motor carriers should audit driver files to identify non-domiciled CDL holders and their visa status, establish contingency plans for potential expirations, and stay current with court rulings that could affect enforcement.

Q7: Do Employment Authorization Documents still work?

ANS: EADs alone are no longer sufficient. Eligible drivers must present both an unexpired passport and a Form I-94 showing H-2A, H-2B, or E-2 status at every issuance, renewal, or upgrade transaction.

Key Takeaways

• The FMCSA’s 2026 Final Rule fundamentally changed who can hold a non-domiciled CDL in the United States, restricting eligibility to H-2A, H-2B, and E-2 visa holders
• DACA recipients, refugees, asylum seekers, TPS holders, and general EAD holders are no longer eligible for new issuance or renewal under the current rule
• Current valid licenses remain valid until expiration, but renewal is only possible if the driver meets the new criteria
• Approximately 194,000 drivers could ultimately be affected as licenses expire over the coming years
• California and other states faced immediate disruption, with court orders and DMV process pauses adding to uncertainty
• Motor carriers should treat this as an ongoing compliance priority, not a one-time update

Where Things Stand Now

The non-domiciled CDL situation is still developing. The Final Rule is in effect, legal challenges are active, and individual states are at different stages of implementing the new requirements. Some drivers who lost licenses are trying to reapply through processes that states are still standing up.

For anyone directly affected — whether you’re a driver, an employer, or an immigration attorney advising clients — the most reliable sources for current status are the FMCSA’s official FAQ page for the 2026 Final Rule, your state’s DMV website, and legal counsel familiar with both transportation and immigration law. The intersection of those two fields is exactly where this rule lives, and it’s changing faster than most regulatory guidance can keep up.

Dr Peter McCullough is one of the most widely recognized — and contested — medical figures of the past several years. Before the COVID-19 pandemic, he was known primarily as a highly published cardiologist and researcher with a deep focus on heart-kidney disease interactions. During and after the pandemic, he became a polarizing public voice, championing early outpatient treatment and raising concerns about COVID-19 vaccines that put him at odds with major medical institutions.

Understanding who he is requires looking at both sides of his story honestly.

Who Is Dr Peter McCullough?

Dr. Peter Andrew McCullough is an American internist and cardiologist born on December 29, 1962, in Buffalo, New York. He earned his bachelor’s degree from Baylor University, then completed his medical degree as an Alpha Omega Alpha graduate — an honor society distinction — from the University of Texas Southwestern Medical School in 1988.

He went on to complete his internal medicine residency at the University of Washington in Seattle, followed by a cardiovascular fellowship at William Beaumont Hospital in Michigan, where he also served as Chief Fellow.

Before the pandemic brought him to wider public attention, McCullough held several prominent clinical and academic positions, including:

• Vice Chief of Internal Medicine at Baylor University Medical Center in Dallas
• Chief of Cardiovascular Research at the Baylor Heart and Vascular Institute
• Program Director of the Cardiovascular Disease Fellowship at Baylor
• Chief Academic and Scientific Officer at St. John Providence Health System in Detroit
• Professor at Texas A&M University College of Medicine

He founded the Cardio Renal Society of America and served as editor of peer-reviewed journals including Reviews in Cardiovascular Medicine and Cardiorenal Medicine. With over 1,000 published papers and hundreds of citations in the National Library of Medicine, he was widely regarded as among the most prolific medical researchers in the United States.

His Research Before COVID-19

McCullough’s pre-pandemic academic work was largely uncontroversial and well-respected. His primary focus was the relationship between heart disease and kidney disease — a field known as cardiorenal medicine.

He is credited as a leading researcher in establishing chronic kidney disease as a significant cardiovascular risk factor. This work has had practical implications: it helped push nephrologists and cardiologists to work together more closely, rather than treating their respective organs in isolation.

He also co-described the term Phidippides cardiomyopathy, a heart condition observed in some endurance athletes who undergo extreme long-distance running — named after the ancient Greek messenger said to have run from Marathon to Athens. This research contributed to a growing body of literature on the cardiac effects of extreme physical exertion.

His chapter “Interface between Renal Disease and Cardiovascular Illness” was included in Braunwald’s Heart Disease, one of the most authoritative textbooks in cardiology. He also received the Simon Dack Award from the American College of Cardiology, a recognition given for outstanding contributions to cardiovascular medicine through scientific writing.

Dr. McCullough and COVID-19

When SARS-CoV-2 began spreading globally in early 2020, McCullough became one of the first physicians to publicly advocate for early outpatient treatment of COVID-19 rather than waiting for patients to deteriorate to the point of hospitalization.

In early 2021, he published a paper in the American Journal of Medicine titled “Pathophysiological Basis and Rationale for Early Outpatient Treatment of SARS-CoV-2 (COVID-19) Infection.” This paper outlined a multi-drug approach using medications such as hydroxychloroquine, ivermectin, zinc, and corticosteroids for high-risk patients in the early stages of infection. He testified before the U.S. Senate Committee on Homeland Security and Governmental Affairs in November 2020 to make the case for this approach.

His advocacy for early treatment — at a time when official guidance offered little to outpatient COVID-19 patients — earned him a following among both medical professionals and the general public who felt mainstream medicine had left patients without options.

However, several of the specific drugs he promoted, including hydroxychloroquine and ivermectin, were evaluated in large randomized clinical trials and found to not provide the benefits he claimed. Public health agencies and major medical organizations did not adopt his protocols, and the scientific consensus did not align with his treatment recommendations.

Vaccine Controversy and Institutional Consequences

McCullough’s claims about COVID-19 vaccines became the most contentious chapter of his public career. He argued that the mRNA vaccines were responsible for a large number of serious adverse events and deaths — figures that went far beyond what regulatory agencies and clinical trial data reported.

He made these claims on high-profile platforms, including an appearance on Joe Rogan’s podcast, which has one of the largest audiences in the world.

In July 2023, he co-authored a preprint claiming that 74% of COVID-19 fatalities were vaccine-induced. That paper was rapidly retracted, and he was separately accused of misrepresenting it as a Lancet publication — a claim disputed by the journal itself.

The American Board of Internal Medicine (ABIM) responded formally. In October 2022, it recommended revocation of McCullough’s board certifications in internal medicine and cardiovascular disease, citing his “provision of false or inaccurate medical information to the public” and his refusal to correct statements that posed safety concerns. By January 2025, the ABIM had revoked both certifications.

The loss of board certification does not automatically mean a physician cannot practice medicine, but it significantly affects hospital privileges and insurance credentialing. McCullough has publicly disputed the ABIM’s process and framed the revocation as institutional censorship rather than a legitimate disciplinary action.

He also parted ways with Baylor Scott & White Health, which filed a breach of contract suit against him and obtained a temporary restraining order to prevent him from using Baylor titles and affiliations. The suit sought $1 million in damages, alleging he continued using institutional affiliations after his separation agreement.

Where He Stands Today

McCullough currently serves as President of the McCullough Foundation, a nonprofit focused on health and geopolitical policy. He is also Chief Scientific Officer of The Wellness Company, a health products and services company.

He runs a widely-read newsletter called FOCAL POINTS on Substack, where he publishes commentary on a range of biomedical and political topics. 

His supporters view him as a physician who challenged a medical establishment too slow to consider dissenting views and too quick to dismiss early treatment options. His critics — including major medical boards, fact-checkers, and peer reviewers — argue that he spread misinformation that undermined public confidence in safe and effective vaccines during a public health emergency.

Key Facts

• Born: December 29, 1962, in Buffalo, New York
• Degrees: BS (Baylor University), MD (University of Texas Southwestern), MPH (University of Michigan)
• Specialty: Internal medicine and cardiovascular disease
• Published over 1,000 peer-reviewed papers cited in the National Library of Medicine
• Received the Simon Dack Award from the American College of Cardiology
• Founded the Cardio Renal Society of America
• Testified before the U.S. Senate on COVID-19 outpatient treatment in November 2020
• American Board of Internal Medicine revoked his certifications in January 2025
• Currently President of the McCullough Foundation and CSO of The Wellness Company

Common Misconceptions

Dr. McCullough’s board certifications were revoked, so he was never a real doctor

He was a fully credentialed and practicing cardiologist for decades, with a legitimate and respected academic career. Board certification revocation is a disciplinary action, not a retroactive disqualification of his prior credentials or training.

His early treatment protocol has been proven to work

Large, randomized controlled trials — the gold standard in clinical research — did not confirm the efficacy of several drugs central to his protocol, particularly hydroxychloroquine and ivermectin for early COVID-19.

He was silenced by the medical establishment

McCullough had access to major podcast platforms, Senate hearings, journal publications, and a large social media following. 

Everything he says about vaccines must be wrong 

Vaccine safety monitoring is an ongoing scientific process, and some adverse effects — including myocarditis in young males after mRNA vaccination — have been confirmed by health agencies. The debate is about frequency, causation, and risk-benefit calculation, not whether any adverse effects exist.

Frequently Asked Questions

Q1: What is Dr Peter McCullough known for?

Ans: He is known for his extensive research in cardiology and cardiorenal medicine, as well as his public advocacy during the COVID-19 pandemic for early outpatient treatment and his criticism of COVID-19 vaccine safety, which led to institutional controversies including the revocation of his medical board certifications.

Q2: Is Dr Peter McCullough still a licensed doctor?

Ans: As of January 2025, the American Board of Internal Medicine revoked his board certifications in internal medicine and cardiovascular disease. Whether he retains a state medical license to practice may vary by jurisdiction. Board certification and state licensure are separate systems.

Q3: What did Dr. McCullough say about COVID-19 vaccines?

Ans: He publicly claimed that COVID-19 vaccines were responsible for a significant number of deaths and serious adverse events, figures substantially higher than those reported by regulatory agencies. Several of his specific claims were disputed and retracted by journals. The ABIM cited these statements in its certification revocation proceedings.

Q4: Why did Baylor University sue Dr. McCullough?

Ans: Baylor Scott & White Health filed a breach-of-contract lawsuit alleging that McCullough continued using Baylor titles and affiliations after signing a separation agreement. The suit sought $1 million in damages.

Q5: What is Dr. McCullough doing now?

Ans: He runs the McCullough Foundation, serves as Chief Scientific Officer at The Wellness Company, writes the FOCAL POINTS newsletter on Substack, and continues to publish research and speak publicly on health and policy topics.

Q6: What was Dr. McCullough’s main research area before COVID-19?

Ans: His primary academic focus was cardiorenal medicine — specifically, the relationship between chronic kidney disease and cardiovascular risk. 

Key Takeaways

• Dr Peter McCullough was a prominent, highly published cardiologist long before COVID-19 brought him to wider public attention.
• His pre-pandemic research in cardiorenal medicine was well-respected, with over 1,000 peer-reviewed publications and major institutional roles.
• His claims about COVID-19 vaccine safety were more extreme than the scientific consensus, leading to formal action by the American Board of Internal Medicine, which revoked his certifications by January 2025.
• His supporters see him as a courageous dissenter. His critics see him as someone who spread misinformation during a public health crisis.
• He remains active through his foundation, a health company, and a large Substack readership.

Conclusion

Dr Peter McCullough represents a genuinely complicated figure in modern medicine. His academic record before the pandemic was substantial and largely uncontested. His pivot to public advocacy during COVID-19 — and the institutional fallout that followed — raises real questions about how medical dissent is handled, what standards apply to physician public statements, and where the line is between clinical heterodoxy and misinformation.